HSP90B1 and neoplasm: A study by Podack and co-workers who constructed a gp96-Ig fusion protein noted an increase in tumour immunogencity in cells transfected with this construct, suggesting that increased hsp secretion can act as a stimulatory signal for the breaking of host immune tolerance (Yamazaki et al, 1999).